Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines.

ABSTRACT:

Background

Pharmaceutical nanomedicine products are expected to impact the global pharmaceutical market and healthcare system significantly. Since 2000, the Food and Drug Administration (FDA) and European Medicines Agency (EMA) have approved over 80 nanomedicine products for marketing; an additional double that number is currently being tested in clinical trials. The nanomedicine market is expected to reach USD 350.8 billion by 2025 from USD 138.8 billion in 2016. This demonstrates the importance of nanotechnology to the delivery of pharmaceuticals. The main benefits of employing nanotechnology to distribute therapeutic agents include reducing the undesired toxicity from non-specific distribution and increasing patient adherence, which can indirectly minimize the burden on the coun

SUBMITTER: Halwani AA 

PROVIDER: S-EPMC10336578 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature